Dr Elizabeth Boudreau, Assistant Professor of Small Animal Neurology at Texas A&M University, USA, has been awarded the 2021 WSAVA Future Leader Award in recognition of her contribution to research and her role as an educator.
Dr Boudreau’s research is primarily focused on the biology of canine brain tumors and, more specifically, on how genetic and immunological features connect with therapeutics. She has active canine clinical trials with MD Anderson Cancer Center collaborators, examining immunotherapies for glioma in dogs with naturally occurring disease. The aim is to fast-pace effective therapeutics to canine and human patients, which are commercially and biologically viable.
In addition to her research, Dr Boudreau has received awards for her teaching. She leads the American College of Veterinary Internal Medicine (ACVIM) neurology residency training program at Texas A&M University and has been invited by ACVIM to present on teaching methodologies.
The WSAVA Future Leader Award acknowledges the work of a veterinarian who graduated within the last 10 years and who has contributed significantly to the betterment of companion animals, the veterinary profession and society at large.
The Award is generously supported by the Purina Institute, a Diamond Partner of the WSAVA.
Professor Jonathan Levine, head of Small Animal Clinical Sciences at Texas A&M University, USA, who nominated Dr Boudreau said: “Dr Boudreau is one of the most promising early-stage clinician-scientists working to define canine glioma. She is also an outstanding clinician and educator. Her accomplishments, considering her career stage, are stellar.”